Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study

AIDS. 2000 Jul 28;14(11):1660-2. doi: 10.1097/00002030-200007280-00025.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Anticholesteremic Agents / adverse effects
  • Anticholesteremic Agents / therapeutic use*
  • Drug Tolerance
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / metabolism
  • HIV Protease
  • HIV Protease Inhibitors / adverse effects*
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1*
  • Humans
  • Hyperlipidemias / chemically induced
  • Hyperlipidemias / drug therapy*
  • Indinavir / adverse effects
  • Indinavir / therapeutic use
  • Male
  • Nelfinavir / adverse effects
  • Nelfinavir / therapeutic use
  • Pilot Projects
  • Pravastatin / adverse effects
  • Pravastatin / therapeutic use*
  • Ritonavir / adverse effects
  • Ritonavir / therapeutic use
  • Saquinavir / adverse effects
  • Saquinavir / therapeutic use
  • Treatment Outcome

Substances

  • Anticholesteremic Agents
  • HIV Protease Inhibitors
  • Indinavir
  • HIV Protease
  • Nelfinavir
  • Pravastatin
  • Saquinavir
  • Ritonavir